← Open Payments lookup

KIMBERLY ALDIS: Open Payments

NPI 1265903447 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,438 in 108 payments from 35 companies in 2025. Trend: 2023 $2,114 · 2024 $2,484 · 2025 $2,438

Food & beverage: $2,244Education: $194
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation17$351
Janssen Biotech, Inc.13$340
Genentech USA, Inc.7$150
ABBVIE INC.5$146
AstraZeneca Pharmaceuticals LP6$135
Merck Sharp & Dohme LLC5$126
Takeda Pharmaceuticals U.S.A., Inc.5$120
Boehringer Ingelheim Pharmaceuticals, Inc.4$103
SOBI, INC6$101
Incyte Corporation3$72

Products named: RYBREVANT, LUTATHERA, IMFINZI, KEYTRUDA, Vonjo, IMBRUVICA, REBLOZYL, KISQALI.

Industry payments across AL — which companies pay providers there.